MEDICAL ADVOCATES

   Medical Advocates for Social Justice

 Kaletra/Aluvia Library Service 
 Abstracts and Posters from the

   

 


 

4th IAS Conference on HIV Pathogenesis
and Treatment and Prevention 

Sydney, Australia








July 22-25
, 2007
 
 

Last Update:  December 08, 2014  
Documents identified with this icon  are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
 
  A WEEK-IN-REVIEW FEATURED REPORT
POSTER
LPV/r-based 2-drug HAART vs LPV/r-based 3-drug HAART: Comparable virological efficacy
and tolerability in HIV-1-infected naïve subjects (Kalead1 study) – 48-Week results
Pinola M, Carosi G, Di Perri G,  et al

PDF Poster
 
A WEEK-IN-REVIEW FEATURED REPORT
POSTER

Soluble immune markers in individuals treated for 6 years with a lopinavir/ritonavir
(LPV/./r)-based antiretroviral (ARV) regimen

Landay A, King M, Tschampa J, et al

PDF Poster
 
A WEEK-IN-REVIEW FEATURED REPORT
POSTER
Ezetimibe Combined with Low Dose Statin Effectively Lowers LDL in Protease Inhibitor
Treated Patients

Klibanov OM, Gaughan JP, Tedaldi EM, et al
PDF Poster
 
A WEEK-IN-REVIEW FEATURED REPORT
POSTER

One-year Fat Tissue Distribution Changes in Antiretroviral Naïve HIV-infected Patients Treated
with Lopinavir/ritonavir (LPV/r) monotherapy versus LPV/r with zidovudine/lamivudine (AZT/3TC)
in the MONARK Trial
Delfraissy JF, Flandre P, Ngo Van P, et al

PDF Poster
 
A WEEK-IN-REVIEW FEATURED REPORT
POSTER

No change in glucose tolerance with lopinavir/ritonavir (LPV/r) + ZDV/3TC induction followed by
LPV/r monotherapy through 96 weeks
da Silva B, King M, Dehaan M, et al

PDF Poster
 
A WEEK-IN-REVIEW FEATURED REPORT
POSTER

Changes in Lipid Parameters During Treatment with Lopinavir/ritonavir (LPV/r) Plus Zidovudine/
lamivudine (ZDV/3TC) Induction Followed by Maintenance on LPV/r Monotherapy Compared to
Efavirenz (EFV) + ZDV/3TC Through 96 Weeks
da Silva B, Domingo P, Joly V, et al

PDF Poster
 

A WEEK-IN-REVIEW FEATURED REPORT
POSTER

Single-agent Therapy with Lopinavir/ritonavir Suppresses Plasma HIV-1 Viral Replication in HIV-
Naïve Subjects: IMANI-2 48-Week Results

Gathe Jr. JC, Yeh RF, Mayberry C, et al
PDF Poster

PK analysis of rifabutin given with lopinavir/ritonavir to persons co-infected with TB and HIV
Boulanger C, Peloquin C, Hollender E, et al
Abstract

 
Therapeutic drug monitoring of lopinavir / ritonavir in HIV infected children
Curras V, Hocht C , Cacers Guido P,  et al
Abstract

 
Meta-analysis of the pharmacokinetics and efficacy of low dose lopinavir/ritonavir (LPV/r)
Hill A., Burger D.
Abstract

Top od the Page


Main New/Newsworthy  Kaletra Conference Data Home

4th IAS Conference on HIV Pathogenesis and Treatment and Prevention  
Kaletra Library Service